Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Comments regarding the '584 Patent's Amended Claim 29

Any chance we can take this one step further? Going to the Markman.

<The dispute is whether an operand that is present in the instruction group must be right justified and whether the instruction group may encompass a single 32-bit traditional conventional instruction.>

I am presuming from the wording of claim 29 that the USPTO disagreed with Ward's claim interpetation requiring the operand to be right justified. What say you?

Opty

Share
New Message
Please login to post a reply